New homes - a step closer
It Takes A City Community Land Trust take delivery of first modular homes.
China’s economic outlook and investment opportunities – beyond 2024
Ting Zhang, our founder and CEO, gave a talk to the business executives of the British Design Fund portfolio companies this week on how the UK’s SMEs grow their business in China:
TTP plc proudly sponsors Cambridge Network’s “Women in STEM: Strategies for an Impactful Career” event
TTP plc, a leading technology and product development company, has been announced as the headline sponsor of the upcoming “Women in STEM: Strategies for an Impactful Career” event.
Protect your website and customers
October is Cyber Security Awareness Month—a perfect opportunity for businesses in Cambridge and Cambridgeshire to strengthen their website security. Granite5 underscores the critical importance of protecting customer data, preventing downtime, and maintaining brand trust. By understanding common threats like malware, DDoS attacks, and phishing, and implementing essential measures such as HTTPS…
Kadans Science Partner breaks ground at new purpose-built commercial science facilities at Merlin Place, North Cambridge
Breaking ground ceremony brings together key stakeholders to celebrate progress in development of new bespoke laboratory facilities Late
International award for ‘Connie the Puppet’ reveals an appetite for change in ethics and compliance
The award-winning project takes an innovative approach to ethics and compliance – making it tangible, accessible, engaging – and most importantly – actionable for all employees.
Cambridge reveals innovation blueprint to become world’s leading science and tech region
With the aim to achieve the same level of innovation in the next 10 years as the last 25 years.
Stevenage Bioscience Catalyst scoops the Most Successful Science Park (Small) Award at UKSPA40 Anniversary Awards
Congratulations to everyone who took part and for a fantastic and insightful conference from UKSPA, The United Kingdom Science Park Association.
Dr Sally Ann Forsyth OBE, CEO of SBC, said:
New blog: What are the benefits of digital pathology?
Digital pathology is used within pathology, computer science and image analysis and is transforming how pathologists diagnose and research diseases. Within this article, we will conduct a deep dive into the benefits of digital pathology.
Optibrium demonstrates superior molecular docking method for small molecules and macrocycles
Surflex-Dock structure-based design method outperforms other molecular docking methods for predicting non-cognate ligand pose of macrocyclic compounds Results published Open Access in Journal of Computer-Aided Molecular Design
The impact of AI on the event production industry: jobs created and lost
Every event we’ve worked on in the last 12 months has in some way mentioned AI (except Munich Beer Festival and Top Clown UK).
Overcoming pharmaceutical and other materials issues before they exist
Two new scientific papers on the conclusions of the 7th Crystal Structure Prediction Blind Test.
eg technology launch Technology Readiness Level (TRL) assessment
Comprised of both a self-assessment diagnostic tool, through which innovators can assess the Techno
Exploring the micro world of PµSL: Accuracy in 3D printing for micro-scale applications
In the realm of 3D printing, rapid advancements in technology are unlocking new possibilities for design engineers, product designers, and engineers. One such breakthrough is Projection Micro Stereolithography (PµSL), a high-resolution additive manufacturing technology that enables the creation of intricate micro-scale structures with unmatched accuracy. This article, by Prototype Projects,…
Harnessing 3D printing for complex jigs and fixtures
In this article, Prototype Projects explore the benefits of using 3D printing for jigs and fixtures, with an overview of key 3D printing technologies that enable these innovations.
Yourgene Health Cystic Fibrosis Base assay receives IVDR accreditation
Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the
Guardtech Group bag third win in two months with West Suffolk Innovation of the Year Award
Haverhill-based cleanroom construction specialists scoop Bury Free Press Awards win for Innovation with portable container business Cleancube Mobile Cleanrooms
Benefits of a Nitrosamine Selective Detector
Nitrosamines, such as N-Nitrosodimethylamine (NDMA), are carcinogenic compounds that can form during the drug manufacturing process and storage under certain conditions.
Ensuring cosmetic safety: the vital role of ATNC analysis
Cosmetics aren't just about enhancing beauty; they're about trust and safety. In the intricate dance of beauty and science, the discovery of nitrosamines within our cherished products has cast a shadow, highlighting the need for safety measures.
Helping rediscover purpose and fulfilment after retirement: Barry’s story
After a long career in engineering, Barry decided to retire when the company closed his office. But adjusting to life outside of work was a struggle – he found it difficult to fill his days and he lost the sense of purpose his job had given him. With the right guidance and support, Barry discovered a new passion that’s now helping him to grow his skills and find fulfilment in the next stage of…
DREAM: Develop, Research, Engineer, Assemble and Manufacture with a Guardtech Cleanrooms modular
The Guardtech Group’s more modest modular specialists are helping applications reach new levels with their affordable yet high-quality systems
New Blog: Revolutionising Early-Stage Breast Cancer Treatment
Revolutionising Early-Stage Breast Cancer Treatment: How the MAF Test® Enhances Precision Care with Biomarker-Driven InsightsThe MAF Test® by Inbiomotion is an advanced diagnostic tool designed to enhance treatment decisions in early-stage breast cancer.
University of Cambridge alumni awarded 2024 Nobel Prize in Chemistry
Two University alumni, Sir Demis Hassabis and Dr John Jumper, have been jointly awarded this year’s Nobel Prize in Chemistry for developing an AI model to solve a 50-year-old problem: predicting proteins’ complex structures.
Milner Therapeutics Institute joins Cambridge-ARIA collaboration to create new technologies for transforming brain health
The Milner Therapeutics Institute (MTI) has joined a three-year collaboration with the science funding agency ARIA and multiple Cambridge partners.
Cambridge Network collaborates with ARIA and key partners to accelerate new technologies to revolutionise brain health
Cambridge Network is thrilled to announce its participation in a multi-million-pound, three-year multi-partner programme with the UK Government’s new research funding agency Advanced Research and Invention Agency (ARIA).